These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 4669960

  • 1. Hypophysectomy for metastatic cancer.
    Ray BS.
    J Med Liban; 1972; 25(5):393-400. PubMed ID: 4669960
    [Abstract] [Full Text] [Related]

  • 2. Hypophysectomy in the treatment of disseminated carcinoma of the breast and prostate gland.
    Tindall GT, Ambrose SS, Christy JH, Patton JM.
    South Med J; 1976 May; 69(5):579-83. PubMed ID: 1273614
    [Abstract] [Full Text] [Related]

  • 3. Treatment of breast cancer with antiestrogen: approach to medical hypophysectomy?
    Manni A, Trujillo J, Brodkey J, Marshall JS, Pearson OH.
    Trans Assoc Am Physicians; 1977 May; 90():342-52. PubMed ID: 611666
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 May; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 5. Transsphenoidal hypophysectomy in the treatment of metastatic breast and prostate carcinoma.
    Silverberg GD, Britt RH.
    West J Med; 1979 Mar; 130(3):191-5. PubMed ID: 425500
    [Abstract] [Full Text] [Related]

  • 6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK.
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [Abstract] [Full Text] [Related]

  • 12. Endocrinologically incomplete transethmoidal trans-sphenoidal hypophysectomy with relief of bone pain in breast cancer.
    LaRossa JT, Strong MS, Melby JC.
    N Engl J Med; 1978 Jun 15; 298(24):1332-5. PubMed ID: 651992
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial.
    Nicolini A, Carpi A.
    Biomed Pharmacother; 2005 Jun 15; 59(5):253-63. PubMed ID: 15913946
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.